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Conformational transition of FGFR 
kinase activation revealed by 
site-specific unnatural amino acid 
reporter and single molecule FRET
Louis Perdios1,2, Alan R. Lowe1,3,4, Giorgio Saladino5, Tom D. Bunney1, Nethaji Thiyagarajan1, 
Yuriy Alexandrov6, Christopher Dunsby6, Paul M. W. French6, Jason W. Chin7, 
Francesco Luigi Gervasio5, Edward W. Tate2 & Matilda Katan1
Protein kinases share significant structural similarity; however, structural features alone are insufficient 
to explain their diverse functions. Thus, bridging the gap between static structure and function 
requires a more detailed understanding of their dynamic properties. For example, kinase activation 
may occur via a switch-like mechanism or by shifting a dynamic equilibrium between inactive and 
active states. Here, we utilize a combination of FRET and molecular dynamics (MD) simulations to 
probe the activation mechanism of the kinase domain of Fibroblast Growth Factor Receptor (FGFR). 
Using genetically-encoded, site-specific incorporation of unnatural amino acids in regions essential 
for activation, followed by specific labeling with fluorescent moieties, we generated a novel class of 
FRET-based reporter to monitor conformational differences corresponding to states sampled by non 
phosphorylated/inactive and phosphorylated/active forms of the kinase. Single molecule FRET analysis 
in vitro, combined with MD simulations, shows that for FGFR kinase, there are populations of inactive 
and active states separated by a high free energy barrier resulting in switch-like activation. Compared 
to recent studies, these findings support diversity in features of kinases that impact on their activation 
mechanisms. The properties of these FRET-based constructs will also allow further studies of kinase 
dynamics as well as applications in vivo.
The central role of protein kinases in physiological processes and their deregulation in a range of diseases have 
motivated extensive studies resulting in a wealth of knowledge, from biological roles to structural detail at an 
atomistic level1,2. Kinases are attractive therapeutic targets and over the past 10 years have become the most 
important class of drug target in the field of cancer3,4. However, it is becoming clear that characterization of 
factors that govern physiological or aberrant activation of protein kinases, or determine drug binding, require 
further insights into their dynamic features5–8.
Fibroblast growth factor receptors (FGFRs) play a critical role in many physiological processes and have been 
implicated in pathogenesis of several developmental syndromes and a broad range of human malignancies; a 
large effort to develop FGFR inhibitors as anticancer treatments is underway9–12. As is generally the case with 
other protein kinases, structural information alone13 is insufficient for understanding their diverse functions 
or to fully guide drug development. The extent to which protein kinases can be differentiated as dynamic sys-
tems is currently unclear, as is the diversity of conformational states they can sample. With respect to activation 
mechanisms it is possible that inactive kinase conformations could be completely energetically isolated from 
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catalytically active conformations, or that the active state is to some extent energetically accessible, resulting in a 
preexisting equilibrium of two functionally distinct states.
Experimental approaches to monitor the dynamic properties of protein kinases at high resolution have been 
based mainly on application of nuclear magnetic resonance (NMR)14,15, however, this approach has been success-
fully applied only to a small number of protein kinases16–21. Due to the difficulties in obtaining experimental data, 
molecular dynamics (MD) simulations have been performed more extensively, providing theoretical calculations 
and working models for dynamic behavior of kinases21–29. These studies have also highlighted the need to use a 
wider range of approaches to illuminate the atomistic dynamics that underpin activation mechanisms or drug 
binding.
In our studies focusing on FGFR1 kinase domain (KD) we have developed complementary experimental 
methodology that will facilitate studies of kinase dynamics; we combined site-specific protein labeling with 
single-molecule Förster resonance energy transfer (smFRET30), particularly suitable to detect dynamic behavior 
within a population31,32. Furthermore, we have also addressed a major obstacle of non-disruptive labeling of target 
regions that are key for the activation process, and therefore functionally sensitive, by applying the genetically 
encoded, site-specific incorporation of unnatural amino acids (UAAs), coupled with rapid and highly specific 
labeling with a chemical reporter33–39. Importantly, using this novel type of FRET-based construct, combined 
with MD simulations, we show that FGFR1 KD displays switch-like activation owing to a high free energy barrier 
between its non-phosphorylated and phosphorylated states, contrasting some recent examples for other kinases 
supporting preexisting equilibrium24,26,40.
Results
FGFR, a model for kinase activation. Kinase domains (KDs) of FGFR1 and FGFR2 have been extensively 
studied and there are over 70 crystal structures covering inactive states, phosphorylated/active states, complexes 
with small molecule inhibitors and variants incorporating disease-linked, activating mutations13. When a rep-
resentative, high–resolution structure of inactive, non-liganded FGFR1 KD (pdb: 4UWY) is compared with the 
active form (FGFR1–3P; pdb: 3GQI) phosphorylated at Y653, Y654 and Y766 (Fig. 1a), repositioning of the acti-
vation loop (A-loop) results in a dramatic ~19 Å change in the positions of critical residues Y653 and Y654. The 
kinase insert region (KI-loop) also appears to adopt a different conformation in the active kinase. In contrast, a 
defined position of the disordered region at the C-terminus (encompassing Y766) may be determined only after 
effector binding to pY766 (as in pdb: 3GQI)41. Conformational changes within these relatively flexible regions 
(A-loop and KI-loop) are embedded in an overall relative movement of the entire N-lobe towards the C-lobe in 
order to facilitate interactions in the catalytic cleft during enzyme catalysis41.
Kinetic and energetic properties are very difficult to evaluate from high-resolution crystal structures, even 
when documented as extensively as in the case of FGFRs. To investigate which conformations are accessible to 
the respective populations of the KD from non-phosphorylated FGFR1 and FGFR1-3P we calculated the full free 
energy landscape of FGFR activation from the inactive (A-loop closed) to the active (A-loop open) structure. As 
the transition takes place on time-scales that are not accessible to conventional molecular dynamics (MD) simu-
lations42, we used a combination of metadynamics and parallel tempering (PTMetaD)43.
For the non-phosphorylated protein, the main minimum is a semi-inactive structure with a partially distorted 
activation loop (Fig. 1b, left), thus falling between the two reference conformations, as previously reported for 
FGFR27 and other receptor tyrosine kinases22,25. In contrast, for the phosphorylated FGFR, the most stable con-
formation is the active one, with a fully extended activation loop (Fig. 1b, right). The free energy of activation is 
accordingly 5.0 kcal/mol for non-phosphorylated FGFR and − 8.0 kcal/mol for the phosphorylated form suggest-
ing a high degree of separation between the two populations.
Generation and characterization of FGFR1 KD incorporating genetically encoded unnatural 
amino acids and tetra-cysteine tag for labeling with fluorogenic reporters. Our approach to 
experimentally monitor conformational changes of individual proteins combines site-specific incorporation of 
small fluorescent dyes in vitro with smFRET. The sites selected for this type of approach reside in the A-loop, 
KI-loop and the C-terminus; precise residues within these regions (Fig. 1a) have been selected based on an initial 
larger screen.
For specific labeling of selected sites within FGFR1 KD (corresponding to H589 and L662), we applied the 
genetically encoded incorporation of UAAs (bearing a bioorthogonal functional group) in E. coli and their sub-
sequent labeling with a chemical reporter in vitro. As described previously35, the incorporation of UAAs such 
as BCNK (Nε -(bicyclo[6.1.0]non-4-yn-9-yl-methoxy) carbonyl- L –lysine) determined by reassignment to 
an amber stop (TAG) codon is based on an engineered pyrrolysyl-tRNA synthetase (PylRS)/tRNACUAPyl pair 
from Methanosarcina barkeri (Mb). Specifically, a system expressing a variant of MbPylRS (Y271M, L274G and 
C313A), designated BCN tRNA synthetase (BCNKRS), was utilized on account of its efficient incorporation of 
BCNK into recombinant proteins36. For labeling of the kinase C-terminus, a tetracysteine (TC) motif was intro-
duced that provides a site for specific dye binding that can be performed in vitro or in cells44.
Constructs used in this study are summarized in Fig. 2a. The control FGFR1 KD protein incorporates 3 tyros-
ine phosphorylation sites with the C-terminal TC-motif (FGFR1K3Y.TC). Two proteins generated by codon 
reassignment (H589BCNK.TC and L662BCNK.TC) resulted in either H589BCNK or L662BCNK replacement; 
both proteins incorporate the TC-motif at the C-terminus (Fig. 2a). To generate a FRET pair, biarsenical dye 
FlAsH-EDT2 (Fluorescein Arsenic Hairpin-binder) was bound to the TC-motif, which forms an N-terminal hair-
pin structure upon thiol-arsenic ligand exchange reaction and the BCNK residue was specifically labeled with a 
tetrazine–tetramethylrhodamine (TAMRA) conjugate (Tet1-TAMRA-X) through a Diels–Alder ligation in vitro 
(Fig. 2b, Supplemental Fig. S1). Both FlAsH and TAMRA-X are initially weakly fluorescent, but become strongly 
fluorescent once attached to the protein.
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To verify that BCNK was specifically incorporated into FGFR1 KD variants, we compared E. coli lysates 
prepared from conditions containing all components or lacking either BCNKRS, tRNACUA or BCNK. Tet-
1-TAMRA-X fluorescence, resulting from the binding to FGFR1 KD variants incorporating BCNK, was only 
observed when all components were present (Fig. 2c). H589BCNK.TC and L662BCNK.TC proteins were 
Figure 1. Insights into activation of FGFR1 from crystal structures and MD simulations. (a) Crystal structures 
of non-phosphorylated (pdb: 4UWY) (left) and phosphorylated (pdb: 3GQI) (right) FGFR1 KD are shown as 
surface representation. The activation loop (A-loop; red) and kinase insert (KI; pink) (bottom views) and the 
region at the C-terminus (C; green) (top, rotated view) are represented as ribbons. Three tyrosine phosphorylation 
sites (Y653 and Y654 in the A-loop and Y766 at the C-terminus) are shown in cyan and residues H589 in the KI 
and L662 in the A-loop are shown in blue. In the non-phosphorylated structure, flexible region at the C-terminus 
is modeled according to the position in the structure of FGFR1 KD-3P. (b) The free energy surfaces of the non-
phosphorylated (left) and phosphorylated (right) FGFR1 KD are shown as a function of the distance from the 
reference inactive A-loop conformation (CV1) and to the distance from the reference inactive A-loop conformation 
(CV2). The contour lines are drawn every 1 kcal/mol. Selected predicted conformations from the top panels are 
linked by arrows to their ribbon representations (bottom panels) depicting the following conformations of FGFR1 
KD: inactive (corresponding to crystal structure in 1a, left), semi-active (corresponding to the energy minimum) 
and active (corresponding to crystal structure in 1a, right and the energy minimum).
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Figure 2. Generation and labeling of FGFR1 KD variants. (a) Schematic representation of FGFR1 KD 
variants (KD; grey), a tetracysteine motif (TC; green) and a C-terminal decahistidine tag (His10; black). Three 
tyrosine phosphorylation sites (Y653, Y654 and Y766) are also indicated. Kinase insert region and activation 
loop are underlined in black and magenta. The control protein is designated FGFR1KD3Y.TC (top). Two FGFR1 
KD variants incorporating replacement of H589 or L662 by BCNK (red spheres) are designated H589BCNK.
TC (middle) and L662BCNK.TC (bottom). Incorporation of a TC motif at the C-terminus enables fluorescent 
labeling with the dye FlAsH-EDT2 (black arrow). (b) Diagram depicting expression (step 1) and labeling 
(step 2) of FGFR1 KD via genetically encoded UAA, BCNK. In the first step, BCNKRS/tRNACUAPyl pair is 
required for incorporation of BCNK to positions corresponding to H689 and L662, directed by reassigned TAG 
codons. In the second step, a bioorthogonal inverse electron-demand Diels-Alder cycloaddition reaction takes 
place between the strained alkyne group in BCNK and the tetrazine moiety in Tet1-TAMRA-X. Structures 
of BCNK and Tet1 are shown while TAMRA-X is represented as a star with increased fluorescence (red) 
upon protein binding. (c) Analysis of incorporation of BCNK into H589BCNK.TC (left) and L662BCNK.TC 
(right) by TAMRA-X fluorescence. Cell lysates were prepared from conditions lacking one of the indicated 
components required for BCNK incorporation and incubated in the presence of Tet1-TAMRA-X; following 
SDS-PAGE, in-gel fluorescence was detected at 532 nm (bottom) and the protein visualized by Coomassie 
Blue staining (top). (d) Purification and labeling of H589BCNK.TC (left) and L662BCNK.TC (right) proteins. 
Samples obtained at different stages of purification were analyzed by SDS-PAGE; lane 1: E. coli pellet before 
induction, lane 2: E. coli pellet after IPTG induction, lane 3: Clarified lysate, lane 4: Immobilized-Metal 
Affinity Chromatography (IMAC) Ni2+ eluate, lane 5: Steptavidin Trap affinity purification eluate, lane 6: Size 
Exclusion Chromatography eluate (top panels).Following single or double labeling of proteins and SDS-PAGE, 
in gel fluorescence was detected at 532 nm and 473 nm and the protein visualized by Coomassie Blue staining 
(bottom panels).See also Supplementary Figs S1 and S2a.
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subsequently isolated, resulting in a purity > 90% (Fig. 2d, top). The time course of protein labeling with FlAsH 
and TAMRA-X (Supplementary Fig. S2a) was comparable with previous reports for other proteins36,44. Further 
single molecule experiments of proteins labeled with FlAsH and TAMRA-X support double labeling of the major-
ity of fluorescent proteins (see next section).
To test the functionality of H589BCNK.TC and L662BCNK.TC proteins, kinase activity was compared to 
FGFR1 KD control (Fig. 3). The ability of H589BCNK.TC and L662BCNK.TC to auto-phosphorylate was retained 
with only small reduction (Fig. 3, left panel) and the Km values for ATP were similar (Fig. 3, right panel). All 
proteins reached saturating levels of auto phosphorylation within 60 min accompanied by a shift on SDS-PAGE 
(Fig. 3, left panel, inset). Our previous characterization of FGFR1 KD-3Y has demonstrated that the key Y resi-
dues became phosphorylated under these conditions and result in an increase in kinase activity27,45. Subsequent 
binding of FlAsH and TAMRA-X to H589BCNK.TC and L662BCNK.TC had minimal effect on kinase activity 
(the values were within 20% of the unlabeled protein). Furthermore, when phosphorylated, the activity of labeled 
H589BCNK.TC and L662BCNK.TC proteins increased from 0.66 ± 0.04 to 2.19 ± 0.36 and from 0.68 ± 0.03 to 
2.42 ± 0.24, respectively; this is comparable to the increase from 0.82 ± 0.03 to 2.74 ± 0.31 for unlabeled WT 
FGFR1 KD (measured as μ M of ADP in ADP-Glo™ Kinase Assay), demonstrating activation of the labeled pro-
teins due to correct phosphorylation also confirmed using mass spectrometry (Supplementary Fig. S2b).
Conditions and parameters for smFRET. Before protein immobilization for smFRET (Fig. 4a), suitable 
photophysical properties of the donor-acceptor pair were confirmed for FGFR1 KD proteins in solution (Fig. 4b). 
The donor/FlAsH-EDT2 attached to the TC motif and acceptor/Tet1-TAMRA-X attached to BCNK in FGFR1 KD 
variants were subjected to excitation and emission scans of the singly and doubly labelled protein (illustrated for 
L662BCNK.TC in Fig. 4b). The data demonstrate distinct profiles (left panel) and FRET between the two fluoro-
phores at a fixed excitation of 488 nm (right panel).
To monitor conformational transitions and states of FGFR1 KD by smFRET we applied “objective-type” total 
internal reflection fluorescence (TIRF) microscopy (Supplementary Material, Supplementary Figs S3 and S4), a 
similar set up as used in previous studies46. smFRET-TIRF required that samples prepared in solution are sub-
jected to immobilisation, in this case of histidine-tagged FGFR1 KD proteins to polyethylene glycol (PEG) sur-
faces using chelated Cu2+ groups (Fig. 4a). Also, an oxygen scavenger system with triplet state quencher was used 
to suppress photo blinking and enhance the photostability of the dyes by reducing photobleaching.
We used alternating-laser excitation (ALEX47) of the donor and acceptor dyes to differentiate the observed 
FRET species in accordance with the number and type of fluorophores present48,49. To calibrate the measure-
ments, correction factors relating to spectral cross-talk (where the donor fluorescence is visible on the acceptor 
emission camera) and cross-activation (where the donor excitation laser directly excites the acceptor dye) were 
determined. These correction factors, in addition to local background subtraction are required for determin-
ing intramolecular proximity changes (see Supplementary Material). Single and double labelled L662BCNK.TC 
proteins were used to determine the correction factors for cross-talk and cross-activation, enabling subsequent 
calculation of the corrected proximity ratio (EPR) and the corrected stoichiometry (S) (Supplementary Material). 
Singly labelled species showed corresponding stoichiometry centered at about 0.95 for FlAsH only and about 
0.05 for TAMRA-X only indicating the presence of single dyes. Double labelled protein showed an intermediate 
factor of about 0.57, suggesting approximately 1:1 FlAsH/TAMRA-X labelling ratio (Fig. 4c). Cross-correlation 
Figure 3. Characterization of FGFR1 KD variants. Kinase activity of FGFR1K3Y.TC (control) and 
H589BCNK.TC and L662BCNK.TC variants was compared. Time-course of auto-phosphoryaltion was 
performed using a bioluminescent ADP-Glo kinase assay (left panel). Samples of H589BCNK.TC and 
L662BCNK.TC before (− ATP) and after 45 min incubation with ATP (+ ATP) were subjected to SDS-PAGE 
and Western blotting using anti-pY653/654 antibody; subsequent staining was with Amido Black (inset). 
Km values for ATP for FGFR1 KD variants (right panel) were calculated from data obtained in a kinase 
assay at increasing concentrations of ATP (0–500 μ M) using poly(E4Y1) peptide as a substrate. See also 
Supplementary Fig. S2b.
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analysis of single molecule time traces of donor and acceptor, from which EPR is calculated, show anti-correlated 
behaviour and demonstrate that intensity fluctuations result from energy transfer (Fig. 4d,e).
Analysis of inactive and active forms of FGFR1 KD. Prior to immobilization for smFRET analysis, 
FGFR1 KD variants were either phosphorylated in the presence of ATP or prepared under control conditions. A 
few hundred individual fluorescent intensity traces (typically > 1000 counts, ranging between 236 to 406 traces) 
were analyzed. Representative EPR-S two-dimensional histograms of FlAsH and TAMRA-X labeled H589BCNK.
TC and L662BCNK.TC proteins are shown in Fig. 5. The population of non-phosphorylated H589BCNK.TC 
kinase exhibits a peak at EPR 0.38 and a unimodal distribution while the phosphorylated form exhibited a peak 
shifted to EPR 0.49 with a slightly broader unimodal distribution (Fig. 5a). FRET fluctuations for both proteins 
likely occur on a very fast timescale (similar to, or faster than the duty cycle of ALEX using our EMCCD acqui-
sition rate), and we do not observe protracted dwells in alternative states, as characterised by the unimodal EPR 
distributions. We note a small upward shift in the S peak between non-phosphorylated and phosphorylated forms 
of both proteins (Fig. 5a,b), suggesting a minor change in quantum yield of one or other of the fluorescent dyes, 
consistent with a subtle changing of their chemical environment47 upon activation of the kinase.
Comparison of non-phosphorylated and phosphorylated forms of L662BCNK.TC kinase revealed an even 
bigger shift of EPR peaks from 0.28 to 0.52 with a similar peak count and a similar unimodal population distri-
bution under phosphorylated conditions (Fig. 5b). Interestingly, under non-phosphorylated conditions, the EPR 
distribution is skewed, suggesting a mixture of two populations, heavily weighted toward a low FRET species 
(80%) with the remainder (20%) as a higher FRET species, perhaps resembling the active form.
Figure 4. Surface immobilization strategy and correction factor retrieval for smFRET. (a) Schematic 
showing the immobilisation of His-tagged protein to the surface coverslip for smFRET-TIRF experiments. The 
immobilized protein maintains its native conformation and activity as a result of the controlled orientation 
and inertness of the chemical surrounding provide by the Cu2+ /PEG surface. (b) Solution measurements 
of emission spectra of L662BCNK.TC labelled with either donor FlAsH-EDT2 (DFM) or acceptor Tet1-
TAMRA-X (AT) or both dyes (DFMAT) at the fixed excitation wavelength: 488 nm for DFM and DFAMTM 
and 561 nm for ATM (left). Emission spectra of the same samples, all at the fixed excitation wavelength of 
488 nm are also shown (right) clearly demonstrating energy transfer from the donor to the acceptor (arrows). 
(c) Differentiation of donor-only, acceptor-only and donor-acceptor subpopulations by Alternating Laser 
EXitation (ALEX). A 2D-histogram/contour plot of the uncorrected stoichiometry (S) values versus the 
apparent FRET efficiency, known as proximity ratio (EPR), shows the position of each subpopulation (donor 
only, green; acceptor only, red; donor + acceptor, blue) determining the contributions of crosstalk of the donor 
emission into the acceptor detection channel and the direct excitation of the acceptor with the donor excitation 
laser. FRET efficiency (EPR) corrections, including accounting for background photons, are further discussed 
in Supplementary Material. (d) An example of a single Tet1-TAMRA-X acceptor dye photobleaching step, 
with corresponding increase in donor FlAsH-EDT2 emission. The photobleaching step manifests a drop in the 
calculated FRET efficiency (EPR). (e) An example of a corrected fluorescence intensity time trace of donor and 
acceptor (upper trace, donor FlAsH-EDT2 in green, acceptor Tet1-TAMRA-X in red) from which EPR (lower 
trace, blue) is calculated. See also Supplementary Figs S3 and S4.
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The mean EPR from three independent experiments is shown in Fig. 5c, showing a statistically significant change 
in EPR between unphosphorylated and phosphorylated forms for both variants of the protein (P < 0.001). All exper-
iments included an additional control in which protein samples were supplemented with adenosine diphosphate 
Figure 5. Comparison of labeled, non-phosphorylated and phosphorylated states of FGFR1 KD by 
smFRET. (a,b) EPR-S 2D histogram plots with projections (bottom: EPR; right: S) of double-labeled H589BCNK.
TC (a) and L662BCNK.TC (b) in non-phosphorylated (N) and phosphorylated (P) states for comparison. The 
1D-histogram subplots (grey bars) are compared to the Gaussian distribution fits (red lines, subpopulations 
in blue). The EPR 1D histogram subplots show a unimodal distribution of events (counts) in all measured 
samples except for L662BCNK.TC in the non-phosphorylated form, which is described by a Gaussian Mixture 
with two components (0.8 and 0.2 respectively) shown in blue. (c) EPR mean from 3 independent experiments 
under phosphorylating (P, orange), non-phosphorylating (N, blue) or control, ADP-supplemented (C, purple) 
conditions. Error bars indicate the standard deviations (SDs). Statistical significance was assessed using one-way 
ANOVA with Bonferroni multiple comparison test (**0.001 < P < 0.01, ***0.0001 < P < 0.001). (d) TR-FRET 
readout of FlAsH-EDT2 and TAMRA-X labeled H589BCNK.TC (left) and L662BCNK.TC (right), comparing 
non-phosphorylated (N) and phosphorylated (P) samples. The fluorescent lifetime decay of the FRET donor 
is determined by fitting into a stretched exponential decay model with the measured instrument response 
function (IRF). See also Supplementary Fig. S5.
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(ADP), instead of ATP, that would occupy the same binding pocket but would not result in phosphorylation. For 
both variants, the ADP control showed a comparable profile to that of non-phosphorylated forms.
Shift of EPR peaks towards higher values (Fig. 5) implies closer spatial proximity of fluorescent dyes and is 
likely to reflect a combination of a more compact structure of phosphorylated kinase and specific repositioning of 
the loop regions. Because FGFR1 KD incorporating all elements required for protein labeling is not structurally 
defined, our model consistent with smFRET data for the two variants, depicts the possible arrangements of rela-
tive distances (Supplementary Fig. S5).
In addition to smFRET we also performed time-resolved fluorescence energy transfer (TR-FRET) studies 
in solution. Despite some differences in the experimental setup and conditions (described in Supplementary 
Material), results from TR-FRET using H589BCNK.TC and L662BCNK.TC proteins labeled with the same 
donor-acceptor pair showed qualitatively similar changes towards closer proximity of the two fluorophores upon 
phosphorylation, indicated by a more rapid donor fluorescence decay (Fig. 5d). These TR-FRET observations are 
consistent with the data obtained by smFRET (Fig. 5a–c), demonstrating that both measurements can distinguish 
and therefore report non-phospho/inactive and phospho/active forms of FGFR1 KD.
Discussion
Despite extensive studies of protein kinases, insights into their dynamic properties that can provide a bridge 
between static structure and function remain limited. Progress in this area requires development of new tools 
including precise FRET-based reporters of dynamic states and conformational transitions and their further analy-
sis using methods such as smFRET, that are capable of capturing large-scale conformational movements. We here 
describe such new tools developed for one of the key signaling protein kinases, FGFR.
We generated a novel class of FRET constructs that directly report differences corresponding to states sampled 
by an inactive or an active signaling kinase. The conformational transitions and dynamic range can be measured 
in solution or using immobilized proteins under physiologically relevant conditions in vitro (Fig. 5) and, in future 
applications, within a cellular environment. These properties have been achieved by specific incorporation of an 
UAA into key functional regions (linked to activation) of the kinase domain without diminishing its activity and 
subsequent labeling together with a TC-label to generate a FRET pair (Fig. 2). The labeling protocol for this genet-
ically encoded UAA, BNCK, has been initially applied to model proteins36 and now there are several examples of 
UAA combined with smFRET to study functionally important proteins (e. g. p9737). Here, we demonstrate that 
despite a comparatively low yield of FGFR1 KD variants, we were able to purify and characterize these proteins 
for smFRET measurements (Figs 2 and 3). Methodologically, these FRET constructs can complement NMR stud-
ies of protein dynamics in vitro15,50 by accessing regions not visible by NMR, such as highly mobile segments of 
the A-loop, and bypass limitations of molecular weight and requirement for large protein quantities. Compared 
to current cellular reporters incorporating GFP derivatives51, the future application of these probes could generate 
direct and localized readouts; they could also provide a basis for a more general strategy covering a wider range of 
signaling kinases by eliminating interference from bulky (genetically encoded) fluorophores.
Furthermore, through a combination of both MD simulations and smFRET experiments, our data suggest a 
high degree of conformational separation between the non-phosphorylated and phosphorylated populations of 
FGFR1 KD. The change in the FRET distances for two FRET-constructs, characterized by a single peak and uni-
modal distribution for each state (Fig. 5a and b), is consistent with a high energy barrier between a semi-inactive 
folded structure, the most stable for non-phosphorylated FGFR, and a fully active one that is the most stable 
conformation sampled by phosphorylated FGFR KD (Fig. 1b). Our findings are also consistent with the presence 
of a “molecular brake” in an inactive state of FGFR KD and similar kinases52, a feature near the hinge region that 
could restrain two kinase lobes and also suppress the catalytically significant DFG flip in the A-loop by imposing 
a particularly high free-energy barrier20.
The data for FGFR1 KD (Figs 1b and 5a–c) are in sharp contrast with recent observations obtained for a 
metabolic phosphoglycerate kinase (PGK)40. MD simulations and smFRET show equilibrium between two pop-
ulations (“expanded” and “compact”) for ligand-free PGK; substrate binding only slightly shifts the equilibrium 
toward the compact state. These data show that PGK is intrinsically a highly dynamic system sampling a wealth of 
conformations and that catalytically relevant conformations are, to a large extent, already occurring in ligand-free 
PGK40. MD simulations have also been performed for several signaling protein kinases including EGFR, Abl, 
Src and B-Raf22–26,28. The EGFR KD, similarly to FGFR KD, may not be able to access active conformations to a 
significant degree unless perturbed by activating mutations22,23,25. Studies of Abl kinase, where the SH2 domain 
has a role in auto-inhibition and activation53,54, provide a contrasting example. Recent MD simulations applied 
to Abl KD in isolation predict an equilibrium between two similarly populated states where the activating role 
of the Abl SH2 domain have been associated with a shift in the equilibrium and lower free energy of the active 
state24. Similarly, B-Raf may also be an example of a “preexisting equilibrium”26. Therefore, protein kinases in their 
non-phosphorylated state or in the absence of regulatory protein-protein interactions, are likely to differ in the 
range of conformational states they can sample and sizes of the corresponding populations. Further theoretical 
and, in particular, experimental approaches such as those applied here to FGFR KD are needed to extend these 
initial studies to a wider range of signaling kinases and application of further dynamic studies to fully determine 
implications of their dynamic properties for regulation, subversion in disease and new strategies for treatment.
Methods
Protein expression and purification. To express FGFR1 KD with the incorporated unnatural amino acid 
BCNK, we transformed E. coli BL21 (DE3) cells with pBKBCNRS plasmid (encodes MbBCNRS) and one of 
p2xStrpII.SUMO*.FGFR1KD3YTAG.TC.His10. PylT plasmids (encode MbtRNACUAPyl and a multi-tagged vari-
ant of FGFR1 KD3Y with an amber TAG codon introduced at a position of H589 or L662 codon). Cells were 
grown at 37 °C in terrific broth (TB) containing carbenicillin and spectinomycin. At a cell density (OD600) of 
www.nature.com/scientificreports/
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0.4 to 0.5, BCNK (2 mM) was added to the culture and at OD600 of 1.0 to 1.2, cultures were cooled to 15 °C and 
expression induced with IPTG (400 μ M). Following cell lysis, FGFR1 KD variants were purified using HisTrap 
FF, StrepTactin Sepharose HP, and a Superdex 200 10/300 GL column. See Supplementary Material for a detailed 
description.
Protein labeling and sample preparation. Purified FGFR1 KD variants were incubated with 
Tet1-TAMRA-X (50 μ M, 20 equiv.) or FlAsH-EDT2 (100 μ M, 40 equiv.) at 25 °C for 1 hour and labelling con-
firmed by in-gel fluorescence. For smFRET experiments, the labeled proteins were incubated in the presence of 
ATP or ADP (150 μ M) or in the absence of nucleotides at 25 °C for 1 hour, prior to immobilization. Further detail 
of protein labeling and sample preparation is described in Supplementary Material.
Single molecule FRET (smFRET) measurements. SmFRET measurements were performed with a 
custom-built objective type laser-illuminated total internal reflection fluorescence microscope with an Olympus 
1.49 N.A. 100X oil immersion objective. The proximity ratio, EPR, corrected for background signal, crosstalk (L), 
and direct excitation (D) was calculated using the fluorescent intensities from video frames according to the fol-
lowing equation: = +E F f F/ D
D
PR
FRET FRET
ex
em  where = − ⋅ − ⋅F f L f D f f, andD x
A m
D x
D m
A x
A m
D x
A mFRET
e
e
e
e
e
e
e
e  is the sig-
nal in the acceptor detection channel after donor excitation, ⋅L fD
D
ex
em is the L corrected signal in the donor channel 
after donor excitation and ⋅D fA
A
ex
em is the signal in the acceptor detection channel (negligible donor excitation). 
Further information about the TIRF microscope, smFRET procedures and TR-FRET can be found in 
Supplementary Material.
Computational calculations. Enhanced-sampling molecular dynamic simulations (parallel-tempering 
metadynamics, PTMetaD) were according to Bussi et al.43 and are described further in Supplementary Material.
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